Skip to Content Skip to Content

Moving away from ‘average,’ toward the individual

In a course from Annenberg’s David Lydon-Staley, seven graduate students conducted single-participant experiments. This approach, what’s known as an “n of 1,” may better capture the nuances of a diverse population than randomized control trials can.
David Lydon-Staley sitting in a chair, pointing at the front of the room.
David Lydon-Staley is an assistant professor of communication and principal investigator of the Addiction, Health, & Adolescence Lab in the Annenberg School for Communication.

Recent Articles

  • More Articles
  • The Fed explained: What it does and why it matters
    Photo of the Federal Reserve facade

    (Image: Lance Nelson)

    The Fed explained: What it does and why it matters

    Former Philadelphia Fed President Patrick Harker and financial historian Peter Conti-Brown, both Wharton professors, unpack the central bank’s origins, its unusual structure, and the quiet ways it shapes the economy

    May 13, 2026

    Fighting oral cancer with bioengineered chewing gum
    A latex-gloved hand hoding a petri dish of medical chewing gum.

    A bioengineered bean gum from the lab of Penn Dental’s Henry Daniell is found to reduce the levels of three microbes associated with head and neck squamous cell cancer to almost zero, without affecting the beneficial bacteria normally found in the mouth.

    (Image: Kevin Monko/Penn Dental Medicine)

    Fighting oral cancer with bioengineered chewing gum

    Research led by Penn Dental’s Henry Daniell shows that antiviral and antibacterial chewing gums reduce the levels of three microbes linked to worse outcomes in oral cancers, paving the way for more effective and affordable therapies.

    Apr 20, 2026